Cost-effectiveness of venous thrombosis prophylaxis after ischemic stroke.
Wade
W E
WE
Department of Pharmacy Practice, College of Pharmacy, University of Georgia, Athens 30602, USA.
D000925:Anticoagulants / Q000191:economics* / Q000627:therapeutic use*; D001458:Bandages; D002561:Cerebrovascular Disorders / Q000150:complications* / Q000191:economics; D006495:Heparin, Low-Molecular-Weight / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D017410:Practice Guidelines as Topic; D011655:Pulmonary Embolism / Q000209:etiology / Q000517:prevention & control; D013924:Thrombophlebitis / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight